Ultrastructural aspects of colchicine ultrasensitivity in CLL lymphocytes.
Abstract
Circulating lymphocytes from patients with chronic lymphatic leukaemia show extreme sensitivity to colchicine, with 80%-90% cell death after exposure to 10(-7) M colchicine for 20 h in vitro. This is 100,000-times greater than the dose required (10(-2) M) for a similarly toxic effect on normal lymphocytes. A time course series of fixations during the 20-h exposure of chronic lymphoid leukaemia (CLL) lymphocytes to 10(-7) colchicine revealed an entire spectrum of ultrastructural alterations well in advance of any sign of cell death, previously only ascertained by nuclear pycnosis in the light microscope. The changes included the appearance of large numbers of intermediate filaments, loss of surface microvilli, mitochondrial alterations and the formation of annulate lamellae. Mitochondrial changes included disruption of the cristae, swelling and tight clumping of the entire mitochondrial population into a single region of the cytoplasm.Citation
Ultrastructural aspects of colchicine ultrasensitivity in CLL lymphocytes. 1981, 7 (1):147-60 Blood CellsJournal
Blood CellsPubMed ID
6892345Type
ArticleLanguage
enISSN
0340-4684Collections
Related articles
- [Thomson's colchicine test in differential diagnosis of lymphocytic leukemia and non-Hodgkin lymphoma].
- Authors: Skotnicki AB, Piastucka B, Zduńczyk A, Lisiewicz J
- Issue date: 1979 Oct
- Colchicine ultrasensitivity of lymphocytes in chronic lymphocytic leukaemia.
- Authors: Wetherley-Mein G, Thomson AE, O'Connor TW, Peel WE, Singh AK
- Issue date: 1983 May
- The defect of lymphocyte locomotion in chronic lymphocytic leukaemia: studies of polarization and growth-dependent locomotion.
- Authors: Wilkinson PC, Islam LN, Sinclair D, Dagg JH
- Issue date: 1988 Mar
- Phorbol ester-induced loss of colchicine ultrasensitivity in chronic lymphocytic leukaemia lymphocytes.
- Authors: O'Connor TW
- Issue date: 1985
- Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids.
- Authors: Galili U, Leizerowitz R, Moreb J, Gamliel H, Gurfel D, Polliack A
- Issue date: 1982 Apr